Core Viewpoint - Medtronic has agreed to acquire Scientia Vascular for $550 million to enhance its product offerings in stroke care [1] Group 1: Acquisition Details - The acquisition is valued at $550 million and aims to expand Medtronic's product line in stroke care [1] - Scientia Vascular, based in Salt Lake City, employs approximately 310 people and specializes in guidewires and catheters for navigating brain blood vessels [1] - The integration of Scientia's products into Medtronic's existing neurovascular suite is expected to enhance support for both hemorrhagic and acute ischemic stroke procedures [1] Group 2: Financial Expectations - Medtronic anticipates the deal will close in the first half of fiscal 2027 [1] - The company expects the acquisition to be minimally dilutive to its adjusted earnings in 2027 and accretive thereafter [1] - Potential earn-out and milestone payments may be included post-acquisition, although specific details were not disclosed [1]